Helping Ivoirians stay healthy since the 1980s.
- Jhpiego helped the Government of Côte d’Ivoire change the national policy to authorize nurses and midwives to prescribe first-line antiretroviral therapy, thereby increasing access among HIV-positive Ivoirians to these lifesaving medicines while also shifting this task from doctors so they can focus on more advanced care needs.
- Jhpiego introduced cervical cancer screening for HIV-positive women at 20 health care facilities, using visual inspection with acetic acid, coupled with immediate treatment (if needed) via cryotherapy. Jhpiego subsequently scaled up this approach to 81 sites and built national capacity to manage the program so that it was successfully handed over to the government in 2015.
- Jhpiego supported the Government of Côte d’Ivoire to develop and implement an integrated chronic care model (including diagnosis and treatment for hypertension and diabetes) for people living with HIV and chronic diseases.
- With the Ministry of Health and Ministry of Education, Jhpiego built the capacity of vaccinators, facilitated the accessibility of vaccinations in schools, and coordinated the introduction of vaccinating 9 year old girls against HPV in all health districts nationwide.
Our Work in Côte d’Ivoire
The overall goal of this project, funded by the U.S. Centers for Disease Control and Prevention (CDC), is to improve the health status of priority populations in targeted districts in Côte d’Ivoire through increased access to high-quality HIV testing, age-appropriate counseling and enrollment in antiretroviral therapy services and follow-up, including adherence support. The project works in close coordination with local nongovernmental and community-based organizations, government counterparts, CDC and other implementing partners, particularly clinical care partners that are delivering HIV services in health facilities in the target regions. In particular, the project is building the capacity (financial and programmatic) of six local nongovernmental organizations.
Jhpiego is supporting Save the Children under the USAID-funded Resources towards Elimination of Child Vulnerability (REVE Côte d’Ivoire) project to strengthen the capacity of families and community networks to ensure the well-being of their most vulnerable members, including persons living with HIV/AIDS, orphans and vulnerable children (OVC) and adolescent girls. Jhpiego serves as the technical lead for clinical linkages and associated training and capacity-building activities under the project goal of increasing utilization of HIV and other health services by vulnerable groups. In particular, Jhpiego provides technical assistance to: 1) strengthen health sector participation in OVC platforms and establish routine information-sharing procedures; 2) strengthen the referral and counter-referral systems to link HIV-affected households to clinical services through social centers and health facilities in the target zones; and 3) train social workers.
The Health Workforce for the 21st Century Project (HW21) is a multi-country initiative funded by the Health Resources and Services Administration under the U.S. President’s Emergency Plan for AIDS Relief. HW21 supports country-level programs to address key human resources for health (HRH) system barriers to achieving 95-95-95 goals (i.e., 90% of people living with HIV knowing their HIV status, 90% of people who know their status on treatment, and 90% of people on treatment with suppressed viral loads). This support is provided through technical and implementation assistance as well as research, analysis and sharing of results to inform program implementation. In Côte d’Ivoire, HW21 aims to increase access to community-level HIV services by supporting the Ministry of Health and Public Hygiene to put into effect a national community health worker (CHW) system by rolling out of the CHW system and developing policies/regulatory processes for CHWs and community-based health facilities. The project is also conducting a situational analysis of CHW roles, competencies and training needs, with a focus on those in support of the 95-95-95 goals, and will adapt the CHW training reference manual to build CHW competency.
This four-year project, funded by the Bill & Melinda Gates Foundation, builds on the PMA2020 project, which used innovative mobile technology to support low-cost, rapid-turnaround surveys monitoring key health and development indicators. PMA is enhancing this survey platform to generate high-quality data and ensure that governments, donors, managers and advocates use this data to make decisions regarding family planning programs. In addition to scaling up the survey platform for more widespread use, this project supports expanding it to include additional technical areas. Co-led by Jhpiego and the Bill & Melinda Gates Institute for Population and Reproductive Health, this project is operational in several African and Asian countries, including Côte d’Ivoire.
Funded by the Bill & Melinda Gates Foundation, this program promotes access to family planning choices in West African countries by supporting the introduction and scale-up of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC). DMPA-SC is an innovative injectable contraceptive—also known as Sayana® Press—that can dramatically expand access and choice for women. Jhpiego is enhancing ongoing efforts of the Access Collaborative by strengthening health systems to accelerate introduction and scale-up of DMPA-SC in several West African countries, including Côte d’Ivoire.
Impact Malaria is a global project of the U.S. President’s Malaria Initiative to reduce mortality and morbidity caused by malaria. Implemented by a consortium of organizations led by PSI, the project is funded by the U.S. Agency for International Development. In close collaboration with the country’s National Malaria Control Program, other sections of the Ministry of Health and various implementing partners, Impact Malaria is designed to improve malaria service delivery via the following objectives: 1) improve the quality of and access to malaria case management and prevention of malaria in pregnancy; 2) improve the quality of and access to other malaria drug-based approaches and provide support to pilot/scale up newer malaria drug-based approaches; and 3) provide global technical leadership, support operational research and advance program learning.
This multi-country project—funded by Gavi, the Vaccine Alliance—targets several African countries. The overarching project goal is to support Ministries of Health with their national vaccination rollout, contributing to the elimination of cervical cancer in the targeted countries by achieving an equitable coverage rate of at least 70% among eligible girls by 2030. To reach this goal, Jhpiego is linking secondary prevention of cervical cancer (i.e., screening for cervical cancer) to primary prevention efforts (i.e., HPV vaccination)—and vice versa. To achieve equitable coverage, Jhpiego is using a multipronged approach to reach in- and out-of-school girls through activities such as school-based campaigns and community-based campaigns to reach out-of-school youth. This multipronged approach focuses on four areas: 1) community engagement with stakeholders and beneficiaries for social mobilization; 2) capacity development of health care providers; 3) vaccination integration into existing programs for adolescent/school health; and 4) ensuring high-quality HPV vaccination services.
Unitaid is funding a consortium, led by Expertise France, that seeks to eliminate cervical cancer in Burkina Faso, Côte d’Ivoire, Guatemala and the Philippines through secondary prevention (i.e., detecting disease early to slow or halt its progress). The three-year SUCCESS project is designed to shift the countries from a largely opportunistic cervical cancer screening model to a systematic approach centered on innovations related to: 1) reinforced and simplified cervical cancer screening through the introduction of human papilloma virus (HPV) testing with self-collection sampling; 2) secondary prevention of cervical cancer including use of efficient methods for treatment of cervical precancerous lesions such as thermal ablation; and 3) intensified dissemination of information on cervical cancer and new preventive technologies. In so doing, SUCCESS aims to support countries to “leapfrog” to a state-of-the-art services model recommended by the World Health Organization. As the implementing partner of the consortium, Jhpiego is integrating and expanding cervical cancer prevention and treatment services into both new and existing platforms, relying on our established relationships with governments and stakeholders in all four countries. Through demand-generation and community engagement activities, the project plans to screen a total of 185,000 women, a significant proportion of whom will be women living with HIV.